Type-1 Cannabinoid Receptor
The use of cannabis (Cannabis sativa) has been known for centuries, but it was necessary to wait until the late 1980s to understand the molecular basis responsible for its medical and recreational properties. Unlike cocaine and morphine, isolated as crystalline salts from coca leaves and opium respectively, the active constituent of cannabis appeared as an oily extract, difficult to isolate in pure form. Only in the 1960s isolation, characterization, and chemical synthesis of the active cannabis constituent, Δ9-tetrahydrocannabinol (THC), was possible. The identification of THC allowed a reevaluation of cannabis pharmacology and gradually boosted research towards the understanding of the molecular and cellular mechanisms underlying its therapeutic efficacy.
Although the existence of THC-binding cannabinoid receptors, and of an even more surprising ensamble of metabolic enzymes and transporters...
KeywordsDopamine Schizophrenia Morphine Cocaine Angiotensin
- Ferreira SG, Gonçalves FQ, Marques JM, Tomé ÂR, Rodrigues RJ, Nunes-Correia I, Ledent C, Harkany T, Venance L, Cunha RA, Köfalvi A. Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission. Br J Pharmacol. 2015;172:1074–86.CrossRefPubMedPubMedCentralGoogle Scholar
- Imperatore R, Palomba L, Morello G, Spiezio AD, Piscitelli F, Marzo VD, Cristino L. Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK phosphorylation. Pharmacol Res. 2016;111:600–9.CrossRefPubMedGoogle Scholar
- Kuliczkowska Plaksej J, Laczmanski L, Milewicz A, Lenarcik-Kabza A, Trzmiel-Bira A, Zaleska-Dorobisz U, Lwow F, Hirnle L. Cannabinoid receptor 1 gene polymorphisms and nonalcoholic fatty liver disease in women with polycystic ovary syndrome and in healthy controls. Int J Endocrinol. 2014;2014:232975.CrossRefPubMedPubMedCentralGoogle Scholar
- Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev. 2010;62:588–631.CrossRefPubMedPubMedCentralGoogle Scholar
- Rossi S, Bozzali M, Bari M, Mori F, Studer V, Motta C, Buttari F, Cercignani M, Gravina P, Mastrangelo N, Castelli M, Mancino R, Nucci C, Sottile F, Bernardini S, Maccarrone M, Centonze D. Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis. PLoS One. 2013;8:e82848.CrossRefPubMedPubMedCentralGoogle Scholar